Evidence map›Paper›PMID 38997610›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2024

Next-generation atrial fibrillation ablation: clinical performance of pulsed-field ablation and very high-power short-duration radiofrequency.

Nibras Soubh, Judith Gronwald, Helge Haarmann, Eva Rasenack, Philipp Bengel, Simon Schlögl, Gerd Hasenfuß, Markus Zabel, Leonard Bergau

Abstract readComparative Study
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nibras SoubhUniversity Medical Center Göttingen (UMG), Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Judith GronwaldUniversity Medical Center Göttingen (UMG), Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Helge HaarmannUniversity Medical Center Göttingen (UMG), Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Eva RasenackUniversity Medical Center Göttingen (UMG), Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Philipp BengelUniversity Medical Center Göttingen (UMG), Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Simon SchlöglUniversity Medical Center Göttingen (UMG), Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Gerd HasenfußUniversity Medical Center Göttingen (UMG), Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Markus ZabelUniversity Medical Center Göttingen (UMG), Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Leonard BergauUniversity Medical Center Göttingen (UMG), Robert-Koch-Str. 40, 37075, Göttingen, Germany. leonard.bergau@med.uni-goettingen.de.ORCID http://orcid.org/0000-0001-7025-9315

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPulsed-field energy (PFA) and very high-power short-duration radiofrequency (vHPSD-RF) are two novel ablation methods for pulmonary vein isolation (PVI). Both PFA and vHPSD-RF show promise for improving efficacy, safety, and reducing procedure durations. However, direct comparisons between these two techniques are scarce. METHODS AND

resultsRetrospective analysis of 82 patients with symptomatic AF. Of these, 52 patients received PFA and 30 received vHPSD-RF (90 W, 4 s) as index procedure. At the 6-month follow-up, AF recurrence occurred in 4 patients following PFA and 5 patients following vHPSD-RF (p-value = 0.138). Significant improvements in the EHRA and NYHA stages were evident in both PFA (p < 0.001 and p = 0.047, respectively) and vHPSD-RF groups (p = 0.007 and p = 0.012, respectively). The total procedure duration and the left atrial dwell time were significantly shorter in the PFA group (64 ± 19 min vs. 99 ± 32 min, p < 0.001 and 41 ± 12 min vs. 62 ± 29 min, p < 0.001, respectively). The fluoroscopy time and dose area product were significantly higher in PFA (14 ± 6 vs. 9 ± 5 min, p < 0.001 and 14 ± 9 vs. 11 ± 9 Gy cm

conclusionBased on this retrospective single-center study, PFA and vHPSD-RF were associated with similar effectiveness and safety profiles. PFA was linked to shorter procedure times and higher radiation exposure compared to vHPSD-RF.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsAgedFemaleHumansMaleMiddle AgedOperative TimeRetrospective StudiesTreatment OutcomeComparisonElectroporationHigh-power short durationPulmonary vein isolationSingle-shot ablation

Identifiers

PMID38997610
PMCPMC11711250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.